Tetyana Korchak, MD
Dr. Korchak has more than 23 years of drug development industry experience across broad indication of neuroscience, supporting studies for small molecules, biologics and cell and gene therapies. Her expertise extends from early phase development through late phase/post-marketing studies in capacity of investigator, operational leader and head of clinical development of autologous cell therapy at a biotech company. As an investigator, Dr. Korchak held various COA certifications, e.g., EDSS, ADAS-cog, MMSE and CDR. Her expertise encompasses neurodegenerative, acute and rare neurology and various psychiatry diseases.